The journey from laboratory research to a market-ready pharmaceutical product is long and complex, with the quality of each component playing a crucial role. At NINGBO INNO PHARMCHEM CO.,LTD., we understand the indispensable nature of high-purity chemical intermediates. This article highlights the significance of (R)-2-Methylbut-3-Enoic Acid, identified by CAS No. 20626-49-7, as a prime example of such a vital material in modern pharmaceutical synthesis.

The designation 'CAS No. 20626-49-7' refers to (R)-2-Methylbut-3-Enoic Acid, a chiral organic compound that serves as a foundational element in the creation of sophisticated medicinal compounds. Its purity level, consistently exceeding 98%, is not merely a technical specification but a guarantee of reliability for sensitive synthetic processes. Coupled with its GMP, ISO 9001, and FDA certifications, this intermediate meets the rigorous demands required for pharmaceutical manufacturing.

The pharmaceutical industry’s reliance on precise chemical structures is exemplified by the use of (R)-2-Methylbut-3-Enoic Acid in the development of Milvexian. As an intermediate in the synthesis of this Factor XIa inhibitor, its exact stereochemistry and purity are critical for the biological activity of the final drug. NINGBO INNO PHARMCHEM CO.,LTD. plays a pivotal role in providing this essential chemical medicine, ensuring that researchers and manufacturers have access to materials that uphold the highest quality standards.

For companies engaged in scientific research or the production of novel therapeutics, the choice of chemical supplier is as important as the choice of the intermediate itself. With (R)-2-Methylbut-3-Enoic Acid (CAS No. 20626-49-7), NINGBO INNO PHARMCHEM CO.,LTD. offers a product that embodies quality, reliability, and the precision necessary for advancing pharmaceutical science.